Dr. Matthew Joseph Tinguely, MD

Dr. Tinguely practices at Sanford Fargo Hospice in Fargo, North Dakota.

Dr. Tinguely's NPI, 1548348410, was assigned on November 1, 2006. Dr. Tinguely graduated from Creighton University School of Medicine in 2004. Dr. Tinguely holds North Dakota license 11676.

Dr. Tinguely's primary practice is Sanford Fargo Hospice, at 801 Broadway North, Fargo, ND 58102 in Cass County. The practice phone is (701) 234-7550.

Dr. Tinguely's primary practice is Sanford Fargo Hospice in Fargo, North Dakota. Dr. Tinguely is also affiliated with Sanford Broadway Medical Center. The medical group on file is Sanford West Fargo Clinic. Dmand AI also links Dr. Tinguely to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tinguely practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Tinguely's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Tinguely's licenses on file in 2 states: North Dakota and Wisconsin.

CMS data shows 480 Medicare services from Dr. Tinguely across 5 procedure codes in 2024, for 218 Medicare patients. Medicare paid $31,003 for them.

CMS counts 218 Medicare patients who saw Dr. Tinguely in 2024. The largest group is 65 to 74, with 100 patients. 69% of them have high blood pressure, and 66% have cancer. 17% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tinguely's median patient age at 71, with 68% women.

In 2024, Dr. Tinguely wrote 587 Medicare Part D claims for 122 patients. 93% of them were for generic drugs. CMS names the drug for 483 of them, across 10 drugs with 11 or more claims each, at $25,047 in total drug cost. In 2023, CMS named 538 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Tinguely for performance year 2024, reported as part of a group. Dr. Tinguely accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Tinguely in 2022. Dr. Tinguely's most frequent co-authors are Elie G. Dib, MD, John H. Lee, MD and Michele M. Lohr, MD.

Dmand AI links Dr. Tinguely to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Squamous Cell Carcinoma of Head and Neck and Carcinoma, Squamous Cell.

CMS Open Payments shows 3 general payments to Dr. Tinguely from 3 drug and device companies from 2018 to 2022. Food and beverage make up the largest share, 63% of the total. Celgene Corporation paid the most, $59.

Dr. Tinguely graduated from Creighton University School of Medicine in 2004.